Sarcoma
Volume 2010 (2010), Article ID 586090, 5 pages
doi:10.1155/2010/586090
Research Article

High-Speed Burring with and without the Use of Surgical Adjuvants in the Intralesional Management of Giant Cell Tumor of Bone: A Systematic Review and Meta-Analysis

1Department of Surgery, McMaster University, Hamilton, ON, L8V 5C2, Canada
2Department of Orthopedic Surgery, McGill University Health Center, Montreal, Québec, Canada

Received 22 March 2010; Accepted 24 June 2010

Academic Editor: R. Pollock

Copyright © 2010 H. Algawahmed et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Campanacci, N. Baldini, S. Boriani, and A. Sudanese, “Giant-cell tumor of bone,” Journal of Bone and Joint Surgery. American, vol. 69, no. 1, pp. 106–114, 1987. View at Scopus
  2. R. E. Turcotte, J. S. Wunder, and J. S. Wunder, “Giant cell tumor of long bone: a Canadian Sarcoma Group study,” Clinical Orthopaedics and Related Research, no. 397, pp. 248–258, 2002. View at Scopus
  3. M. Balke, L. Schremper, and L. Schremper, “Giant cell tumor of bone: treatment and outcome of 214 cases,” Journal of Cancer Research and Clinical Oncology, vol. 134, no. 9, pp. 969–978, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  4. M. Rock, “Curettage of giant cell tumor of bone. Factors influencing local recurrences and metastasis,” La Chirurgia Degli Organi di Movimento, vol. 75, no. 1, pp. 204–205, 1990. View at Scopus
  5. Y.-P. Su, W.-M. Chen, and T.-H. Chen, “Giant-cell tumors of bone: an analysis of 87 cases,” International Orthopaedics, vol. 28, no. 4, pp. 239–243, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  6. S. Gitelis, B. A. Mallin, P. Piasecki, and F. Turner, “Intralesional excision compared with en bloc resection for giant-cell tumors of bone,” Journal of Bone and Joint Surgery. American, vol. 75, no. 11, pp. 1648–1655, 1993. View at Scopus
  7. H. R. Blackley, J. S. Wunder, A. M. Davis, L. M. White, R. Kandel, and R. S. Bell, “Treatment of giant-cell tumors of long bones with curettage and bone- grafting,” Journal of Bone and Joint Surgery. American, vol. 81, no. 6, pp. 811–820, 1999. View at Scopus
  8. M. A. Ghert, M. Rizzo, J. M. Harrelson, and S. P. Scully, “Giant-cell tumor of the appendicular skeleton,” Clinical Orthopaedics and Related Research, no. 400, pp. 201–210, 2002. View at Scopus
  9. R. J. O'Donnell, D. S. Springfield, H. K. Motwani, J. E. Ready, M. C. Gebhardt, and H. J. Mankin, “Recurrence of giant-cell tumors of the long bones after curettage and packing with cement,” Journal of Bone and Joint Surgery. American, vol. 76, no. 12, pp. 1827–1833, 1994. View at Scopus
  10. V. O. Lewis, A. Wei, T. Mendoza, F. Primus, T. Peabody, and M. A. Simon, “Argon beam coagulation as an adjuvant for local control of giant cell tumor,” Clinical Orthopaedics and Related Research, no. 454, pp. 192–197, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  11. W. T. Becker, J. Dohle, and J. Dohle, “Local recurrence of giant cell tumor of bone after intralesional treatment with and without adjuvant therapy,” Journal of Bone and Joint Surgery. American, vol. 90, no. 5, pp. 1060–1067, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  12. H. R. Dürr, M. Maier, V. Jansson, A. Baur, and H. J. Refior, “Phenol as an adjuvant for local control in the treatment of giant cell tumour of the bone,” European Journal of Surgical Oncology, vol. 25, no. 6, pp. 610–618, 1999. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  13. K. B. Jones, B. R. DeYoung, J. A. Morcuende, and J. A. Buckwalter, “Ethanol as a local adjuvant for giant cell tumor of bone,” The Iowa Orthopaedic Journal, vol. 26, pp. 69–76, 2006. View at Scopus
  14. A. H. Kivioja, C. Blomqvist, and C. Blomqvist, “Cement is recommended in intralesional surgery of giant cell tumors: a Scandinavian Sarcoma Group study of 294 patients followed for a median time of 5 years,” Acta Orthopaedica, vol. 79, no. 1, pp. 86–93, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  15. M. M. Malawer, J. Bickels, I. Meller, R. G. Buch, R. M. Henshaw, and Y. Kollender, “Cryosurgery in the treatment of giant cell tumor: a long term followup study,” Clinical Orthopaedics and Related Research, no. 359, pp. 176–188, 1999. View at Scopus
  16. B. R. Radev, J. A. Kase, M. J. Askew, and S. D. Weiner, “Potential for thermal damage to articular cartilage by PMMA reconstruction of a bone cavity following tumor excision: a finite element study,” Journal of Biomechanics, vol. 42, no. 8, pp. 1120–1126, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  17. U. Quint, R. T. Müller, and G. Müller, “Instillation in intralesional tumor excision of chondroblastoma, osteoclastoma and enchondroma,” Archives of Orthopaedic and Trauma Surgery, vol. 117, no. 1-2, pp. 43–46, 1998. View at Publisher · View at Google Scholar · View at Scopus
  18. U. Quint, U. Vanhöfer, A. Harstrick, and R. T. Müller, “Cytotoxicity of phenol to musculoskeletal tumours,” Journal of Bone and Joint Surgery. British, vol. 78, no. 6, pp. 984–985, 1996. View at Scopus
  19. B. W. W. Grout and G. J. Morris, “Contaminated liquid nitrogen vapour as a risk factor in pathogen transfer,” Theriogenology, vol. 71, no. 7, pp. 1079–1082, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  20. G. Rockswold and D. J. Buran, “Inhalation of liquid nitrogen vapor,” Annals of Emergency Medicine, vol. 11, no. 10, pp. 553–555, 1982. View at Scopus
  21. C. Errani, P. Ruggieri, and P. Ruggieri, “Giant cell tumor of the extremity: a review of 349 cases from a single institution,” Cancer Treatment Reviews, vol. 36, no. 1, pp. 1–7, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  22. K. Trieb, P. Bitzan, S. Lang, M. Dominkus, and R. Kotz, “Recurrence of curetted and bone-grafted giant-cell tumours with and without adjuvant phenol therapy,” European Journal of Surgical Oncology, vol. 27, no. 2, pp. 200–202, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  23. K. Slim, E. Nini, D. Forestier, F. Kwiatkowski, Y. Panis, and J. Chipponi, “Methodological index for non-randomized studies (minors): development and validation of a new instrument,” ANZ Journal of Surgery, vol. 73, no. 9, pp. 712–716, 2003. View at Publisher · View at Google Scholar · View at Scopus
  24. H. W. Boons, L. C. M. Keijser, H. W. B. Schreuder, M. Pruszczynski, J. A. M. Lemmens, and R. P. H. Veth, “Oncologic and functional results after treatment of giant cell tumors of bone,” Archives of Orthopaedic and Trauma Surgery, vol. 122, no. 1, pp. 17–23, 2002. View at Scopus
  25. G. H. Prosser, K. G. Baloch, R. M. Tillman, S. R. Carter, and R. J. Grimer, “Does curettage without adjuvant therapy provide low recurrence rates in giant-cell tumors of bone?” Clinical Orthopaedics and Related Research, no. 435, pp. 211–218, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. K. Benson and A. J. Hartz, “A comparison of observational studies and randomized, controlled trials,” The New England Journal of Medicine, vol. 342, no. 25, pp. 1878–1886, 2000. View at Publisher · View at Google Scholar · View at Scopus
  27. J. Concato, N. Shah, and R. I. Horwitz, “Randomized, controlled trials, observational studies, and the hierarchy of research designs,” The New England Journal of Medicine, vol. 342, no. 25, pp. 1887–1892, 2000. View at Publisher · View at Google Scholar · View at Scopus